198
Views
29
CrossRef citations to date
0
Altmetric
Original Articles

MicroRNA-495 Regulates Migration and Invasion in Prostate Cancer Cells Via Targeting Akt and mTOR Signaling

, , , , &
Pages 181-188 | Received 10 Nov 2015, Accepted 17 Feb 2016, Published online: 31 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jiangfeng Li, Haixiang Shen, Haiyun Xie, Yufan Ying, Ke Jin, Huaqing Yan, Song Wang, Mingjie Xu, Xiao Wang, Xin Xu & Liping Xie. (2019) Dysregulation of ncRNAs located at the DLK1‑DIO3 imprinted domain: involvement in urological cancers. Cancer Management and Research 11, pages 777-787.
Read now
Hai Sun, Yingjian Wang & Wenyu Zhang. (2019) Propofol inhibits proliferation and metastasis by up-regulation of miR-495 in JEG-3 choriocarcinoma cells. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 1738-1745.
Read now

Articles from other publishers (27)

Amirhosein Maharati, Faezeh Tolue Ghasaban, Iman Akhlaghipour, Negin Taghehchian, Amir Sadra Zangouei & Meysam Moghbeli. (2023) MicroRNA-495: a therapeutic and diagnostic tumor marker. Journal of Molecular Histology 54:6, pages 559-578.
Crossref
Letícia Ferreira Alves & Murilo Vieira Geraldo. (2023) MiR-495-3p regulates cell migration and invasion in papillary thyroid carcinoma. Frontiers in Oncology 13.
Crossref
Farnoush Kabiri, Abdallah Medlej, Ali Jason Saleh, Nasser Aghdami, Mona Khani & Bahram M. Soltani. (2023) Downregulated miR-495-3p in colorectal cancer targets TGFβR1, TGFβR2, SMAD4 and BUB1 genes and induces cell cycle arrest. Cancer Treatment and Research Communications 35, pages 100702.
Crossref
. (2020) Retracted : microRNA‐495 alleviates endothelial cell inflammatory injury in coronary heart disease via blockade of the NF‐κB pathway by targeting RALB . Journal of Cellular Physiology 237:3, pages 1994-1994.
Crossref
Adeleh Poursaleh, Farnaz Sadegh Beigee, Golnaz Esfandiari & Mohammad Najafi. (2021) Adhesion of monocytes and endothelial cells isolated from the human aorta suppresses by miRNA-PEI particles. BMC Cardiovascular Disorders 21:1.
Crossref
Ali G. Alkhathami, Amit Kumar Verma, Mohammed Alfaifi, Lalit Kumar, Mohammad Yahya Alshahrani, Abdulrahim R. Hakami, Osama M. Alshehri, Mohammed Asiri & Mirza Masroor Ali Beg. (2021) Role of miRNA-495 and NRXN-1 and CNTN-1 mRNA Expression and Its Prognostic Importance in Breast Cancer Patients. Journal of Oncology 2021, pages 1-10.
Crossref
Shao-Jun Liu, Zhao-Qi Li, Xiao-Yan Wang, Fen Liu, Zhi-Ming Xiao & De-Cai Zhang. (2021) lncRNA UCA1 induced by SP1 and SP3 forms a positive feedback loop to facilitate malignant phenotypes of colorectal cancer via targeting miR-495. Life Sciences 277, pages 119569.
Crossref
B. Baptista, M. Riscado, J.A. Queiroz, C. Pichon & F. Sousa. (2021) Non-coding RNAs: Emerging from the discovery to therapeutic applications. Biochemical Pharmacology 189, pages 114469.
Crossref
Chunhui DongBo FanZongtao RenBin LiuYanchao Wang. (2021) Expression of Concern Issued: CircSMARCA5 Facilitates the Progression of Prostate Cancer Through miR-432/PDCD10 Axis. Cancer Biotherapy and Radiopharmaceuticals 36:1, pages 70-83.
Crossref
Chen Du, Caihong Lv, Yue Feng & Siwen Yu. (2020) Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Fengling Chen, Ling Liu & Shuya Wang. (2020) Long non-coding RNA NORAD exhaustion represses prostate cancer progression through inhibiting TRIP13 expression via competitively binding to miR-495-3p. Cancer Cell International 20:1.
Crossref
Gholamreza Rezaei Danbaran, Saeed Aslani, Nadia Sharafkandi, Maryam Hemmatzadeh, Ramin Hosseinzadeh, Gholamreza Azizi, Farhad Jadidi-Niaragh, Farhad Babaie & Hamed Mohammadi. (2020) How microRNAs affect the PD-L1 and its synthetic pathway in cancer. International Immunopharmacology 84, pages 106594.
Crossref
Getulio Pereira de OliveiraJr.Jr., Eric Zigon, Gaenna Rogers, Danny Davodian, Shulin Lu, Tijana Jovanovic-Talisman, Jennifer Jones, John Tigges, Sanjay Tyagi & Ionita Calin Ghiran. (2020) Detection of Extracellular Vesicle RNA Using Molecular Beacons. iScience 23:1, pages 100782.
Crossref
Eun-Gyo Kim, Jung Oh Kim, Han Sung Park, Chang Soo Ryu, Jisu Oh, Hak Hoon Jun, Jong Woo Kim & Nam Keun Kim. (2019) Genetic associations between the miRNA polymorphisms miR-130b (rs373001), miR-200b (rs7549819), and miR-495 (rs2281611) and colorectal cancer susceptibility. BMC Cancer 19:1.
Crossref
Zhiqiang ChenHaiyi Hu. (2019) Retracted: Identification of Prognosis Biomarkers of Prostatic Cancer in a Cohort of 498 Patients from TCGA . Journal of Computational Biology 26:12, pages e1487-e1498.
Crossref
Zhiqiang Chen & Haiyi Hu. (2019) Identification of prognosis biomarkers of prostatic cancer in a cohort of 498 patients from TCGA. Current Problems in Cancer 43:6, pages 100503.
Crossref
Homa Mollaei, Reza Safaralizadeh & Zeinab Rostami. (2019) MicroRNA replacement therapy in cancer. Journal of Cellular Physiology 234:8, pages 12369-12384.
Crossref
Dingyun Li, Tao Zhang, Jiajun Lai, Jian Zhang, Ting Wang, Yafei Ling, Shengquan He & Zhiwei Hu. (2019) MicroRNA‑25/ATXN3 interaction regulates human colon cancer cell growth and migration. Molecular Medicine Reports.
Crossref
Weirong Chen, Gaoyang Cai, Ziqun Liao, Kaihuang Lin, Guangrong Li & Yanchong Li. (2019) miRNA‑766 induces apoptosis of human colon cancer cells through the p53/Bax signaling pathway by MDM4. Experimental and Therapeutic Medicine.
Crossref
Longkun Lv, Qiang Wang, Yucheng Yang & Honghai Ji. (2018) MicroRNA‑495 targets Notch1 to prohibit cell proliferation and invasion in oral squamous cell carcinoma. Molecular Medicine Reports.
Crossref
Olga E. Bryzgunova, Maria Yu Konoshenko & Pavel P. Laktionov. (2018) MicroRNA‐guided gene expression in prostate cancer: Literature and database overview. The Journal of Gene Medicine 20:5.
Crossref
Ying Ye, Juhua Zhuang, Guangdong Wang, Saifei He, Suiliang Zhang, Guoyu Wang, Jing Ni, Jiening Wang & Wei Xia. (2017) MicroRNA‑495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin‑like growth factor receptor‑1. Experimental and Therapeutic Medicine.
Crossref
Yamin Liu, Mei Wang, Yunquan luo, Jian Chen, Yiyu lu, Yulin Shi, Chenchen Tang, Qianmei Zhou, Hui Zhang, Yuanjia Hu, Shibing Su & Qilong Chen. (2017) MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis. Scientific Reports 7:1.
Crossref
Zhenyou Zou, Ruyi Zou, Dan Zong, Yonghong Shi, Jinyao Chen, Jie Huang, Jiahui Zhu, Liguan Chen, Xiaoyan Bao, Yuan Liu, Weihao Liu, Wenhui Huang, Jingsang Hu, Zhi Chen, Xiaojie Lao, Chaoqun Chen, Xiaoli Huang, Yao Lu, Xueyin Ni, Daoquan Fang, Dengqiang Wu, Shuangshuang Lu, Mingzhu Jiang, Chenyang Qiu, Yuya Wu, Qisha Qiu, Yanyuan Dong, Yangyang Su, Chenmin Zhao, Zhihe Zhong, Jing Cai & Yong Liang. (2017) miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression. Journal of Cellular and Molecular Medicine 21:9, pages 1929-1943.
Crossref
Yi Chen, Donglin Luo, Wuguo Tian, Zhirong Li & Xiaohua Zhang. (2017) Demethylation of miR-495 inhibits cell proliferation, migration and promotes apoptosis by targeting STAT-3 in breast cancer. Oncology Reports 37:6, pages 3581-3589.
Crossref
Weibo Jiang, Jia Zheng, Tao Yu & Jincheng Wang. (2017) Overexpression of microRNA-495 suppresses the proliferation and invasion and induces the apoptosis of osteosarcoma cells by targeting high-mobility group nucleosome-binding domain 5. Oncology Reports 38:2, pages 1099-1107.
Crossref
Weidan Ji, Bin Sun & Changqing Su. (2017) Targeting MicroRNAs in Cancer Gene Therapy. Genes 8:1, pages 21.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.